99 related articles for article (PubMed ID: 3010014)
1. Characterization of immunotherapeutic agents: the example of imuthiol.
Renoux G
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):45-50. PubMed ID: 3010014
[TBL] [Abstract][Full Text] [Related]
2. [Immunopharmacology and pharmacology of diethyldithiocarbamate (DIC)].
Renoux G
J Pharmacol; 1982; 13 Suppl 1():95-134. PubMed ID: 6287113
[No Abstract] [Full Text] [Related]
3. Favorable influences of imuthiol on mouse reproduction and immune system of offspring.
Renoux G; Guillaumin JM; Renoux M
Am J Reprod Immunol Microbiol; 1985 Jul; 8(3):101-6. PubMed ID: 2992301
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and immunological activity of dialkyloamine- and N-piperidinederivatives of dithiocarbamic acid.
Pomorski J; Kowalczyk-Bronisz SH; Mojsiejewska D
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):217-22. PubMed ID: 1338683
[TBL] [Abstract][Full Text] [Related]
5. The ten commandments for immunotherapeutic drugs at the example of sulfur-containing agents.
Renoux G
Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):121-9. PubMed ID: 3024903
[TBL] [Abstract][Full Text] [Related]
6. The influence of diethyl-dithiocarbamate ('Imuthiol') on mononuclear cells in vitro.
Corke CF
Int J Immunopharmacol; 1984; 6(3):245-7. PubMed ID: 6086540
[TBL] [Abstract][Full Text] [Related]
7. Clinical characterization of imuthiol.
Lemarie E; Musset M; Charbonnier C; Renoux M; Renoux G
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):51-4. PubMed ID: 3010015
[TBL] [Abstract][Full Text] [Related]
8. Sodium diethyldithiocarbamate (imuthiol) and cancer.
Renoux G; Renoux M; Lemarie E; Lavandier M; Greco J; Bardos P; Lang JM; Boilleto A; Oberling F; Armand J
Adv Exp Med Biol; 1983; 166():223-39. PubMed ID: 6316766
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacology and immunotoxicity of zinc diethyldithiocarbamate.
Renoux G; Renoux M; Guillaumin JM
Int J Immunopharmacol; 1988; 10(4):489-93. PubMed ID: 2844687
[TBL] [Abstract][Full Text] [Related]
10. Effects of diethyldithiocarbamate on human natural killer cells.
Renoux G
J Immunol; 1984 Oct; 133(4):2278. PubMed ID: 6088635
[No Abstract] [Full Text] [Related]
11. [Methodological problems of screening immunotropic agents].
Uteshev BS
Farmakol Toksikol; 1984; 47(3):5-13. PubMed ID: 6610565
[TBL] [Abstract][Full Text] [Related]
12. Effect of herbal preparation on immune response of immunosuppressed mice.
Sharma SB; Ray S
Indian J Physiol Pharmacol; 1997 Jul; 41(3):293-6. PubMed ID: 10232777
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
Wieczorek Z; Słoń J; Siemion IZ
Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
[TBL] [Abstract][Full Text] [Related]
14. [Immunotoxicity assessment in the preclinical study of biologically active compounds].
Uteshev BS; Arzamastsev EV
Eksp Klin Farmakol; 1996; 59(3):3-8. PubMed ID: 8974580
[TBL] [Abstract][Full Text] [Related]
15. Influence of sodium diethyldithiocarbamate (Imuthiol) on lymphocyte function and growth in weanling pigs.
Flaming KP; Thaler RC; Blecha F; Nelssen JL
Comp Immunol Microbiol Infect Dis; 1988; 11(3-4):181-7. PubMed ID: 2851408
[TBL] [Abstract][Full Text] [Related]
16. Optimal dithiocarbamate structure for immunomodulator action.
Topping RJ; Jones MM
Med Hypotheses; 1988 Sep; 27(1):55-7. PubMed ID: 2849708
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation in autoimmune diseases.
Gergely P; Láng I; Gonzalez-Cabello R; Fehér J
Tokai J Exp Clin Med; 1986; 11 Suppl():207-13. PubMed ID: 3452243
[TBL] [Abstract][Full Text] [Related]
18. Importance of immunotoxicity in safety assessment: a medical toxicologist's perspective.
Descotes J
Toxicol Lett; 2004 Apr; 149(1-3):103-8. PubMed ID: 15093254
[TBL] [Abstract][Full Text] [Related]
19. [The immunotropic properties of biologically active products obtained from Klamath weed (Hypericum perforatum L.)].
Evstifeeva TA; Sibiriak SV
Eksp Klin Farmakol; 1996; 59(1):51-4. PubMed ID: 8704635
[TBL] [Abstract][Full Text] [Related]
20. [Effect of drug preparations on IgE antibody production].
Ionov ID
Farmakol Toksikol; 1986; 49(4):105-8. PubMed ID: 3530803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
